All treatments
Treatment
Matched Placebo for Test clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A randomized, double-blind, placebo-controlled, proof of concept study assessing the efficacy and safety of an anti-TNF-OX40L NANOBODY® molecule, SAR442970, in participants with moderate to severe hidradenitis suppurativa
This study is testing a new medicine, SAR442970, for people with moderate to severe hidradenitis suppurativa (HS). It aims to see if the medicine is safe and helps improve HS symptoms and pain, compared to a dummy treatment.
For: Hidradenitis suppurativaBelgium · Netherlands · Sweden - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab monotherapy by subcutaneous injection in participants aged 12 years and older with moderate-to-severe atopic dermatitis.
This study is testing a new medicine, amlitelimab, for moderate-to-severe eczema in people aged 12 and over. It compares amlitelimab to a dummy medicine (placebo) to see if it improves eczema symptoms like itching and skin clearing.
For: Dermatitis atopicCzechia · Portugal · Bulgaria